HBV Mutation Detail Information

> V173L Search Result

Mutation Information

Mutation Site	V173L
Mutation Type	Amino acid level
Gene/Protein/Region Type	RT
Relevant Drug	lamivudine (LAM)
Country	Spain

Literature Information

PubMed PMID	23602529
Disease	Chronic hepatitis B
Published Year	2013
Journal	Enfermedades infecciosas y microbiologia clinica
Title	[Low prevalence of hepatitis B virus primary drug resistance in Southern Spain].
Author	Alvarez Estévez M,Chueca-Porcuna N,Guillot-Suay V,Peña-Monje A,García-García F,García-García F
Evidence	RtV173L, a lamivudine compensatory mutation, was detected in two patients (1.9%), rtI233V in one patient, and another one carried the sG145R vaccine escape mutation.

Contents
Description

Mutation Information Note

Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)

Literature Information Note

Evidence: sentence contains this mutation information in the citation